Worldwide Healthcare Trust Plc Cash Flow Conversion Efficiency

Latest as of September 2025: -0.002x

Worldwide Healthcare Trust Plc cash flow conversion efficiency. Based on the latest financial reports, Worldwide Healthcare Trust Plc (WWH) has a cash flow conversion efficiency ratio of -0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-3.15 Million ≈ $-383.14 USD) by net assets (GBX1.44 Billion ≈ $175.73K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Worldwide Healthcare Trust Plc (2012–2025)

Cash flow conversion efficiency of Worldwide Healthcare Trust Plc from 2012 to 2025. This chart illustrates how Worldwide Healthcare Trust Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Worldwide Healthcare Trust Plc stock price today for real-time trading data and today's change.

Worldwide Healthcare Trust Plc Cash Flow Conversion Ratio Explained

Worldwide Healthcare Trust Plc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Worldwide Healthcare Trust Plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Worldwide Healthcare Trust Plc ranked by their cash flow conversion efficiency. Also see Worldwide Healthcare Trust Plc market cap and net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Fade Gida Yatirim Sanayi Ticaret As
IS:FADE
0.001x
Binah Capital Group, Inc. Common Stock
NASDAQ:BCG
0.054x
Bukit Jalil Global Acquisition 1 Ltd. Ordinary Shares
NASDAQ:BUJA
-0.014x
Superdong Fast Ferry Kien Giang JSC
VN:SKG
N/A
Mycron Steel Bhd
KLSE:5087
0.016x
Zodiac Clothing Company Limited
NSE:ZODIACLOTH
-0.076x
Mohenz.Co.Ltd
KQ:006920
0.017x
Gabriel Resources Ltd
V:GBU
0.080x

Annual Cash Flow Conversion Efficiency for Worldwide Healthcare Trust Plc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Worldwide Healthcare Trust Plc from 2012 to 2025. Review Worldwide Healthcare Trust Plc (WWH) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 GBX1.68 Billion
≈ $204.33K
GBX-1.54 Million
≈ $-187.86
-0.001x -184.56%
2024-03-31 GBX2.08 Billion
≈ $253.13K
GBX2.26 Million
≈ $275.22
0.001x -56.65%
2023-03-31 GBX2.15 Billion
≈ $261.68K
GBX5.39 Million
≈ $656.29
0.003x +142.68%
2022-03-31 GBX2.27 Billion
≈ $275.98K
GBX-13.33 Million
≈ $-1.62K
-0.006x -1603.13%
2021-03-31 GBX2.38 Billion
≈ $289.75K
GBX931.00K
≈ $113.28
0.000x -71.57%
2020-03-31 GBX1.54 Billion
≈ $187.17K
GBX2.12 Million
≈ $257.33
0.001x -6.90%
2019-03-31 GBX1.43 Billion
≈ $174.24K
GBX2.12 Million
≈ $257.33
0.001x -23.13%
2018-03-31 GBX1.10 Billion
≈ $133.95K
GBX2.12 Million
≈ $257.33
0.002x +132.42%
2015-03-31 GBX982.51 Million
≈ $119.54K
GBX-5.82 Million
≈ $-708.49
-0.006x -887.15%
2014-03-31 GBX636.19 Million
≈ $77.41K
GBX479.00K
≈ $58.28
0.001x -89.41%
2013-03-31 GBX504.42 Million
≈ $61.37K
GBX3.58 Million
≈ $436.19
0.007x -18.20%
2012-03-31 GBX391.80 Million
≈ $47.67K
GBX3.40 Million
≈ $414.17
0.009x --

About Worldwide Healthcare Trust Plc

LSE:WWH UK Asset Management
Market Cap
$18.07 Million
GBX148.53 Billion GBX
Market Cap Rank
#25267 Global
#275 in UK
Share Price
GBX393.00
Change (1 day)
+0.26%
52-Week Range
GBX325.50 - GBX399.00
All Time High
GBX399.00
About

Worldwide Healthcare Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. The fund is managed by OrbiMed Capital LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on pharmaceutical and biotechnology companies. It primarily invests in growth stocks of large-cap … Read more